The biotechnology company initiated first-in-human testing of its therapeutic DNA vaccine candidate for HIV treatment in Hong ...
Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications ...
The Star on MSNOpinion
Editorial: Don’t abuse anti-HIV drug
Kenya is preparing to introduce Lenacapavir, a long-acting HIV prevention injection that will be available next month.It is a ...
Sexually transmitted diseases (STDs), also called sexually transmitted infections (STIs), are far more common than many ...
The New Times on MSN
Rwandans react to planned six-month HIV prevention injection
The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting ...
Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy ...
This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...
The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Experts say the Trump administration is using foreign aid to impose anti-human rights ideology globally ...
HONG KONG SAR - Media OutReach Newswire - 26 January 2026 - Immuno Cure BioTech ("Immuno Cure") is pleased to announce today the initiation of a Phase I clinical study of ICVAX, a therapeutic DNA ...
Gamma irradiation, an industry-standard sterilization method for medicinal and recreational cannabis, does not fully ...
Woman's World on MSN
Can the New At-Home HPV Test, Teal Wand, Really Replace Pap Smears?
If you've been putting off scheduling your Pap smear-maybe for months, maybe longer-take a deep breath. There's no judgment ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果